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Abstract
Purpose: The purpose of this study was to detect diagnostic accuracy of mammography and ultrasound combined 
versus ultrasound alone in early evaluation of symptomatic breast lesions.
Materials and Methods: All new patients who presented to the breast clinic with symptomatic breast lesions, during 
the year 2012, were included in the study. A total of 695 patients were registered. Their clinical findings, mammogram, 
ultrasound and histopathology were reviewed.
Results: Mammogram and ultrasound combined detected 693 (99.71%) lesions in total. Mammogram failed to detect 
lesions in 1.43% of patients, whereas the failure rate of ultrasound was 0.43%. The incidence of microcalcifications 
on mammogram was 19.13%.
Conclusion: Ultrasound is a useful tool in the initial evaluation of symptomatic breasts. For places such as Pakistan 
where mammogram is not available at every centre, ultrasound can be used as an effective alternative for the assessment 
of symptomatic breast lesions.
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Introduction
Breast cancer is the most common cause of cancer-related 
deaths amongst the female gender. Amongst the Asian 
countries, Pakistan has the highest risk of breast cancer; 
one out of every nine Pakistani women carries the risk 
of breast cancer.[1,2] Breast cancer arises from the inner 
lining of the ductal system (ductal carcinoma) or it arises 
from the lobules (lobular carcinoma).[3] Incidence of breast 
cancer in Pakistan was 45.9% according to data of a single 
institution. In a developing country such as Pakistan, 
mammography screening programs are not available 
due to limited resources since mammography is costly; 
therefore, only affording patients on individual basis can 
undergo screening mammograms.[4] Presentation is usually 
with palpable breast lesions or even locally advanced; 
this is due to the lack of awareness and affordability for 
diagnosis and treatment.[5] Breast imaging is indicated 
for screening purposes, evaluation of symptomatic 
breast lumps and planning for the management of 
breast cancer. Mammogram and ultrasound are the 
most common modalities; magnetic resonance imaging 
(MRI) is used less commonly. Other modalities include 
Scintimammography, single-photon emission computed 
tomography and positron emission tomography.[6,7]
The aim of breast imaging is to detect breast cancer in its 
earliest stage so that curative treatment can be planned. The 
earlier the detection, the better the survival. Mammogram 
and ultrasound are the most common investigations for 
screening and evaluation of breast lesions. The incidence 
of breast cancer-related deaths can be reduced by 30%, 
in screening of patients. Screening mammogram can 
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detect suspicious lesions such as micro calcifications, 
architectural distortion and asymmetry, even before the 
lump becomes palpable.[8]
Breast imaging reporting and data system (BIRADS) is 
a risk assessment tool in mammography, ultrasound or 
MRI. There are six categories of BIRADS as follows;[9,10]
• BIRADS 0 – Incomplete
• BIRADS I – Negative
• BIRADS II – Benign findings
• BIRADS III – Probably benign
• BIRADS IV – Suspicious abnormality
• IV A – Low suspicion of malignancy
• IV-B – Intermediate suspicion
• IV C – Moderate suspicion
• BIRADS V – Highly suggestive of malignancy
• BIRADS VI – Known biopsy-proven malignancy.
Mammography uses low-energy X-rays to examine 
the breast. Ultrasound differentiates between solid 
and cystic lesions. When mammogram is combined 
with ultrasound, the diagnostic accuracy increases.[8,9] 
However,mammography is expensive and not commonly 
available in Pakistan. Ultrasound, on the other hand, is a 
more commonly available modality for detecting breast 
lesions. The purpose of our study is to compare the 
diagnostic accuracy of mammogram and ultrasound versus 
mammogram alone versus ultrasound alone.
Materials and Methods
Permission from the ethical committee of the hospital 
was taken for retrieving and publication of data. We 
retrospectively reviewed the data of all the registered 
female breast cancer patients during the year 2012 at 
our institute. Only patients with symptomatic breast 
lesions and proven cancers on final pathology were 
included. The clinical findings, their mammogram and 
ultrasound at initial presentation were reviewed from the 
hospital records. Patients who had undergone incisional 
or excisional biopsies without prior mammogram were 
excluded. We also excluded patients who underwent 
screening breast imaging and were asymptomatic. Patients 
who visited breast clinics for the evaluation of palpable 
lumps, lumpiness breast, nipple discharge, skin changes 
and nipple changes of recent onset were included in the 
study.
After detailed clinical examination, the patients were 
subjected to mammogram and ultrasound, ultrasound-
guided core biopsy of the suspicious lesion or ill-defined 
density. These patients had two view mammogram, 
mediolateral and craniocaudal, followed by ultrasound 
evaluation of breasts and axillae. Ultrasound examination 
was performed in the supine position with ipsilateral arm 
raised. All ultrasound examinations were performed by 
dedicated breast radiologists. Core biopsy was performed 
on all patients under ultrasound guidance. At the same 
occasion, fine-needle aspiration cytology of borderline 
and suspicious axillary lymph nodes was performed. The 
age range was 32–68 years. Patients were divided into 
two age groups, <50 years and 50 and above. Reports of 
these patients were reviewed by two investigators. Clinical 
examination, mammograms and ultrasound findings 
of these patients were compared. Patients who had a 
mammogram were further divided into five subgroups; 
patients who had well-defined lesion on mammogram; 
patients who mass and microcalcifications; patients who 
only microcalcifications; patients who had ill-defined 
density, asymmetry, architectural distortion, vague 
density or area of thickening; and patients who negative 
mammogram. Sonographic findings were grouped into 
positive and negative ultrasounds.
Results
A total of 695 patients constitute the study population. The 
age range was 32–68 years, 365 (51.6%) patients were 
685 (98.56%) patients whereas ultrasound was positive 
in 692 or (99.5%) patients.
Of the 10 patients missed on mammogram, 8 were picked 
up by ultrasound. Only three patients had a failure to 
demonstrate lesion on ultrasound, one of which was 
demonstrated on mammogram. Both mammogram and 
ultrasound were negative in two cases, but these patients 
had Paget’s disease of the nipple.
Details of mammogram and ultrasound findings in both 
the age groups are illustrated in Table 1. Mammogram 
was a better modality for detecting lesions in the elderly 
as it missed 7 (1.0%) lesions in younger age group and 
only 3 (0.43%) lesions in the old age group. Younger 
patients had dense breast and when subjected to additional 
ultrasound, lesions were well demonstrated in all the 
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patients; therefore, in dense breast, ultrasound was more 
useful.
The incidence of microcalcifications was 19.13%. 
Patients who had only microcalcifications but no lesion 
on mammogram, presented with mastalgia and heaviness 
in the breast, showed an associated mass when subjected 
to additional ultrasound [Figure 1]. The sensitivity of 
mammogram alone was 98.84% and ultrasound 99.8%, 
and mammogram combined modality had a sensitivity of 
100%. Mammogram and ultrasound combined have high 
detection rate (99.71%), failure rate of USG was 0.43%, 
while that of mammogram was 1.43% [Table 2].
Discussion
Breast cancer is the most common malignant tumours 
of females. It is one of the five leading causes of cancer-
related deaths in women all over the world.[11] Breast 
cancer is the most common malignancy in Pakistani 
women, and its incidence is highest amongst the Asian 
countries, 2.5 times higher as compared to India and 
Iran.[12-14] Patients usually present at advanced stages due 
to lack of awareness or resources. Only a few patients 
can afford or have access to mammography for detecting 
breast lesions.[5] About 63% of patients usually present 
at stage III or IV. There are few leading hospitals in the 
country dedicated for cancer treatment.[13] Our institution 
has a dedicated breast surgery unit. Since most of our 
patients are those who have symptomatic breast lesions, 
our study could not be done on generalised population. 
Therefore, our study included only those patients who 
presented with symptomatic breasts lesions.
We compared the sensitivity of mammogram and 
ultrasound alone and in combination of both the modalities. 
The aim of combining ultrasound with mammogram is to 
increase the cancer detection rate in the early stages. Our 
results showed that sensitivity of combined modalities is 
greater in detection of breast lesions. However, ultrasound 
was more effective in detecting these lesions as compared 
to mammogram. For a developing country like Pakistan 
where the facility of mammography is not easily available, 
ultrasound may be used as primary imaging modality 
because it is cost effective and easily available. Osako 
et al. showed that sensitivity of ultrasound is 100% in 
clinically palpable lesions.[15]
The results of our study are supported by Gonzaga, who 
studied the accuracy of ultrasound in evaluation of palpable 
breast lesions; overall sensitivity of ultrasound was 92.5%, 
while it was 57.1% in detection of breast cancers. Positive 
Table 1: Mammogram and ultrasound findings 
according to age groups






Mass only 254 (36.54) 241 (34.67)
Mass and micro-
calcifications
62 (8.92) 63 (9.06)
Asymmetry/archi-
tectural distortion
37 (5.32) 20 (2.87)
Microcalcifica-
tions only
5 (0.71) 3 (0.43)
Negative 7 (1) 3 (0.43)
Ultrasound findings
Positive 364 (52.3) 328 (47.19)
Negative 1 (0.14) 2 (0.28) 
Figure 1: Microcalcifications on mammogram
Table 2: Mammogram versus ultrasound
Modality No. of patients
Mammogram and ultrasound positive 680 (97.84)
Mammogram negative 10 (1.43)
Ultrasound negative 3 (0.43)
Both negative 2 (0.28)
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predictive value was 68.1% and negative predictive 
value was 99.5%. Study proposed that ultrasound may 
be used as primary imaging modality in patients under 
the age of 30 years with palpable lesions.[16] Therefore, 
it is a reliable tool for the evaluation of palpable breast 
lesions. Ultrasound is easily assessable for patients, and 
ultrasound-guided core biopsies are better representatives 
than blind cores; nowadays, it has become a popular 
modality in the evaluation of symptomatic breast lesions.
The results of our study are also supported by the findings 
of McCavert et al. who compared clinical findings with 
pathology in patients undergoing triple assessments, and 
their results showed higher sensitivity of mammogram 
and ultrasound combined as compared to mammogram 
alone.[17]
Moss et al. assessed the ability of mammography and 
ultrasound in combination to predict whether breast 
abnormality is benign or malignant in patients with 
symptomatic breast lesions, and they found that extensive 
use of ultrasound increases the detection of cancer rate by 
14% in the selected group of patients.[18]
Our study was retrospective, so only histopathology-
proven cancers were included. Only a single lesion was 
missed on ultrasound which was detected by mammogram, 
and stereotactic core was done for biopsy.
Devolli-Disha et al. compared the accuracy of 
mammography and ultrasound in women with breast 
symptoms according to age and breast density, their results 
also support our study and sensitivity and specificity of 
ultrasound were greater than mammography in patients 
in younger symptomatic patients with dense breasts.[19]
In our study population, ultrasound sensitivity was higher 
as compared to mammography in patients <50 years. 
Therefore, ultrasound can be used not only in the evaluation 
of symptomatic breast lesions but also it can be used as a 
screening tool in selected group of patients, to conserve 
resources in a developing country like Pakistan. Thomas 
et al. compared performance of screening mammography, 
physical examination and ultrasound in 11,130 patients, and 
they concluded that sensitivity of mammography declines 
with increasing breast density and addition of ultrasound 
screening significantly increases the detection of small 
cancers.[20] The detection benefits of screening ultrasound 
in high-risk women are now well validated.[21-24]
Mammography is very sensitive in the detection of 
microcalcifications, but because benign calcifications 
cannot always be distinguished from those malignant, the 
specificity of mammography remains low. Only 20–35% 
of the cases will prove to be cancerous after stereo wire 
localisation biopsy of clustered microcalcifications. 
High-frequency ultrasound can detect masses associated 
with microcalcifications. Benign microcalcifications are 
not detected on ultrasound because they occur in breast 
parenchyma. Moon et al. carried out a prospective study 
to determine whether ultrasound performed with a high-
frequency transducer can demonstrate breast masses 
associated with mammographically detected clustered 
microcalcifications without mass density. At ultrasound, 
breast masses associated with mammographically detected 
microcalcifications were seen in 45 (45%) of 100 cases, 
23% in benign and 82% in malignant microcalcifications.[25]
In our study, only eight patients had clustered 
microcalcifications but no mass on mammogram; 
however, ultrasound in addition to mammogram detected 
these calcifications with well-defined mass. Ultrasound-
guided core biopsy was performed and these were biopsy-
proven carcinomas.
Conclusion
Ultrasound has a higher sensitivity for detecting breast 
lesions as compared to mammogram in younger age group 
(<40 years). Microcalcifications seen on mammogram 
need careful evaluation by an additional ultrasound by a 
experienced radiologist to rule out associated masses. In 
developing countries such as Pakistan, ultrasound may be 
used as primary screening modality, especially in younger 
patients with symptomatic breast lesions.
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